Small RNA sequencing of sessile serrated polyps identifies microRNA profile associated with colon cancer

Genes Chromosomes Cancer. 2019 Jan;58(1):23-33. doi: 10.1002/gcc.22686. Epub 2018 Nov 18.

Abstract

Sessile serrated adenoma/polyps (SSA/Ps) of the colon account for 20-30% of all colon cancers. Small non-coding RNAs, including microRNAs (miRNAs), may function as oncogenes or tumor suppressor genes involved in cancer development. Small RNA sequencing (RNA-seq) was used to characterize miRNA profiles in SSA/Ps, hyperplastic polyps (HPs), adenomatous polyps and paired uninvolved colon. Our 108 small RNA-seq samples' results were compared to small RNA-seq data from 212 colon cancers from the Cancer Genome Atlas. Twenty-three and six miRNAs were differentially expressed in SSA/Ps compared to paired uninvolved colon and HPs, respectively. Differential expression of MIR31-5p, MIR135B-5p and MIR378A-5p was confirmed by RT-qPCR. SSA/P-specific miRNAs are similarly expressed in colon cancers containing genomic aberrations described in serrated cancers. Correlation of miRNA expression with consensus molecular subtypes suggests more than one subtype is associated with the serrated neoplasia pathway. Canonical pathway analysis suggests many of these miRNAs target growth factor signaling pathways.

Keywords: RNA sequencing; colon cancer; gene expression; hyperplastic polyps; microRNAs; sessile serrated adenoma/polyps.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenoma / genetics*
  • Adenoma / pathology
  • Aged
  • Animals
  • Biomarkers, Tumor / genetics
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology
  • Colonic Polyps / genetics*
  • Colonic Polyps / pathology
  • Female
  • Humans
  • Male
  • MicroRNAs / genetics*
  • Middle Aged
  • Sequence Analysis, RNA
  • Thoracica / genetics

Substances

  • Biomarkers, Tumor
  • MicroRNAs